Study on bronchus expansion effect on COPD patient of glycopyrronium bromide
Not Applicable
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000011848
- Lead Sponsor
- national center for global health and medicine respiratory department
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The patient whom the examination responsibility (assignment) doctor judged to be unsuitable as a subject is excluded. Lung tumor or the case in which a metastatic pulmonary tumor was accepted is excepted.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of change of medical treatment start before of 3rd the 6th airway area (mm2) in three-dimensional respiratory tract analysis software, and two weeks after
- Secondary Outcome Measures
Name Time Method The amount of change of 3rd the 6th airway area in three-dimensional respiratory tract analysis software The difference of the amount of change of a COPD assessment test